26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
A judge in the U.S. District Court for the Central District of California recently granted a defenda...
Read More >
The recently updated Construction Contractors Technical Assistance Guide (“TAG”) provides construc...
Read More >
Potential merger partners of and investors in businesses that have received loans under the Paycheck...
Read More >
Nous vous proposons, dans cette newsletter, de revenir sur les nouvelles règles applicables au détac...
Read More >
On Monday, August 17, 2020, Baker Donelson's Clinton Sanko sat down with Wendell Jisa, CEO of Reveal...
Read More >
Rock Health called the landmark Teladoc-Livongo deal a starter pistol for the virtual care platform ...
Read More >